Figure 4From: Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndromePradigastat plasma concentration-time profile. Footnote: Data presented as mean ± standard deviation.Back to article page